Cargando…
Gastric carcinosarcoma with FGFR2 amplification under long-term control with pazopanib: a case report and literature review
BACKGROUND: Gastric carcinosarcoma is most frequently diagnosed at an advanced stage when the tumor is generally large with invasion into other organs, lymph node metastasis, and distant metastasis. Standard chemotherapy has not been established, and surgery is the only curative treatment. Here, we...
Autores principales: | Hayashi, Hirokatsu, Makiyama, Akitaka, Okumura, Naoki, Yasufuku, Itaru, Saigo, Chiemi, Takeuchi, Tamotsu, Miyazaki, Tatsuhiko, Tanaka, Yoshihiro, Matsuhashi, Nobuhisa, Murase, Katsutoshi, Takahashi, Takao, Futamura, Manabu, Yoshida, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331120/ https://www.ncbi.nlm.nih.gov/pubmed/35902814 http://dx.doi.org/10.1186/s12876-022-02432-5 |
Ejemplares similares
-
Late recurrent gastric carcinoma 12 years after surgery with attenuation of CD44 variant 9 expression
por: Hayashi, Hirokatsu, et al.
Publicado: (2023) -
Adiponectin‐expressing Treg‐containing T cell fraction inhibits tumor growth in orthotopically implanted triple‐negative breast cancer
por: Chikaishi, Wakana, et al.
Publicado: (2023) -
Potential activity of adiponectin‐expressing regulatory T cells against triple‐negative breast cancer cells through the cell‐in‐cell phenomenon
por: Chikaishi, Wakana, et al.
Publicado: (2023) -
Efficacy of pazopanib in FGFR1-amplified uterine carcinosarcoma: A case report
por: Sawayama, Saki, et al.
Publicado: (2022) -
Anti-fibrotic properties of an adiponectin paralog protein, C1q/TNF-related protein 6 (CTRP6), in diffuse gastric adenocarcinoma
por: Iwata, Yoshinori, et al.
Publicado: (2021)